Request for Covid-19 Impact Assessment of this Report
The United States Coagulation Factor XI market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Coagulation Factor XI market, reaching US$ million by the year 2028. As for the Europe Coagulation Factor XI landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Coagulation Factor XI players cover Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, and eXithera Pharmaceuticals, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor XI market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coagulation Factor XI Market Size 2017-2028
2.1.2 Coagulation Factor XI Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Coagulation Factor XI Segment by Type
2.2.1 MR-1007
2.2.2 IONIS-FXIRx
2.2.3 EP-7041
2.2.4 AB-022
2.2.5 BMS-262084
2.2.6 Others
2.3 Coagulation Factor XI Market Size by Type
2.3.1 Coagulation Factor XI Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Coagulation Factor XI Market Size Market Share by Type (2017-2022)
2.4 Coagulation Factor XI Segment by Application
2.4.1 Thrombosis
2.4.2 Bleeding and Clotting Disorders
2.4.3 Acute Ischemic Stroke
2.4.4 Others
2.5 Coagulation Factor XI Market Size by Application
2.5.1 Coagulation Factor XI Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Coagulation Factor XI Market Size Market Share by Application (2017-2022)
3 Coagulation Factor XI Market Size by Player
3.1 Coagulation Factor XI Market Size Market Share by Players
3.1.1 Global Coagulation Factor XI Revenue by Players (2020-2022)
3.1.2 Global Coagulation Factor XI Revenue Market Share by Players (2020-2022)
3.2 Global Coagulation Factor XI Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Coagulation Factor XI by Regions
4.1 Coagulation Factor XI Market Size by Regions (2017-2022)
4.2 Americas Coagulation Factor XI Market Size Growth (2017-2022)
4.3 APAC Coagulation Factor XI Market Size Growth (2017-2022)
4.4 Europe Coagulation Factor XI Market Size Growth (2017-2022)
4.5 Middle East & Africa Coagulation Factor XI Market Size Growth (2017-2022)
5 Americas
5.1 Americas Coagulation Factor XI Market Size by Country (2017-2022)
5.2 Americas Coagulation Factor XI Market Size by Type (2017-2022)
5.3 Americas Coagulation Factor XI Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coagulation Factor XI Market Size by Region (2017-2022)
6.2 APAC Coagulation Factor XI Market Size by Type (2017-2022)
6.3 APAC Coagulation Factor XI Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Coagulation Factor XI by Country (2017-2022)
7.2 Europe Coagulation Factor XI Market Size by Type (2017-2022)
7.3 Europe Coagulation Factor XI Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coagulation Factor XI by Region (2017-2022)
8.2 Middle East & Africa Coagulation Factor XI Market Size by Type (2017-2022)
8.3 Middle East & Africa Coagulation Factor XI Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Coagulation Factor XI Market Forecast
10.1 Global Coagulation Factor XI Forecast by Regions (2023-2028)
10.1.1 Global Coagulation Factor XI Forecast by Regions (2023-2028)
10.1.2 Americas Coagulation Factor XI Forecast
10.1.3 APAC Coagulation Factor XI Forecast
10.1.4 Europe Coagulation Factor XI Forecast
10.1.5 Middle East & Africa Coagulation Factor XI Forecast
10.2 Americas Coagulation Factor XI Forecast by Country (2023-2028)
10.2.1 United States Coagulation Factor XI Market Forecast
10.2.2 Canada Coagulation Factor XI Market Forecast
10.2.3 Mexico Coagulation Factor XI Market Forecast
10.2.4 Brazil Coagulation Factor XI Market Forecast
10.3 APAC Coagulation Factor XI Forecast by Region (2023-2028)
10.3.1 China Coagulation Factor XI Market Forecast
10.3.2 Japan Coagulation Factor XI Market Forecast
10.3.3 Korea Coagulation Factor XI Market Forecast
10.3.4 Southeast Asia Coagulation Factor XI Market Forecast
10.3.5 India Coagulation Factor XI Market Forecast
10.3.6 Australia Coagulation Factor XI Market Forecast
10.4 Europe Coagulation Factor XI Forecast by Country (2023-2028)
10.4.1 Germany Coagulation Factor XI Market Forecast
10.4.2 France Coagulation Factor XI Market Forecast
10.4.3 UK Coagulation Factor XI Market Forecast
10.4.4 Italy Coagulation Factor XI Market Forecast
10.4.5 Russia Coagulation Factor XI Market Forecast
10.5 Middle East & Africa Coagulation Factor XI Forecast by Region (2023-2028)
10.5.1 Egypt Coagulation Factor XI Market Forecast
10.5.2 South Africa Coagulation Factor XI Market Forecast
10.5.3 Israel Coagulation Factor XI Market Forecast
10.5.4 Turkey Coagulation Factor XI Market Forecast
10.5.5 GCC Countries Coagulation Factor XI Market Forecast
10.6 Global Coagulation Factor XI Forecast by Type (2023-2028)
10.7 Global Coagulation Factor XI Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Coagulation Factor XI Product Offered
11.1.3 Bayer AG Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Information
11.2.2 Bristol-Myers Squibb Company Coagulation Factor XI Product Offered
11.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bristol-Myers Squibb Company Main Business Overview
11.2.5 Bristol-Myers Squibb Company Latest Developments
11.3 Cambryn Biologics LLC
11.3.1 Cambryn Biologics LLC Company Information
11.3.2 Cambryn Biologics LLC Coagulation Factor XI Product Offered
11.3.3 Cambryn Biologics LLC Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Cambryn Biologics LLC Main Business Overview
11.3.5 Cambryn Biologics LLC Latest Developments
11.4 eXithera Pharmaceuticals, Inc
11.4.1 eXithera Pharmaceuticals, Inc Company Information
11.4.2 eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Offered
11.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 eXithera Pharmaceuticals, Inc Main Business Overview
11.4.5 eXithera Pharmaceuticals, Inc Latest Developments
11.5 Ionis Pharmaceuticals, Inc.
11.5.1 Ionis Pharmaceuticals, Inc. Company Information
11.5.2 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Offered
11.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ionis Pharmaceuticals, Inc. Main Business Overview
11.5.5 Ionis Pharmaceuticals, Inc. Latest Developments
11.6 LegoChem Biosciences, Inc
11.6.1 LegoChem Biosciences, Inc Company Information
11.6.2 LegoChem Biosciences, Inc Coagulation Factor XI Product Offered
11.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 LegoChem Biosciences, Inc Main Business Overview
11.6.5 LegoChem Biosciences, Inc Latest Developments
12 Research Findings and Conclusion
Table 1. Coagulation Factor XI Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of MR-1007
Table 3. Major Players of IONIS-FXIRx
Table 4. Major Players of EP-7041
Table 5. Major Players of AB-022
Table 6. Major Players of BMS-262084
Table 7. Major Players of Others
Table 8. Coagulation Factor XI Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Coagulation Factor XI Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Coagulation Factor XI Market Size Market Share by Type (2017-2022)
Table 11. Coagulation Factor XI Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Coagulation Factor XI Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Coagulation Factor XI Market Size Market Share by Application (2017-2022)
Table 14. Global Coagulation Factor XI Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Coagulation Factor XI Revenue Market Share by Player (2020-2022)
Table 16. Coagulation Factor XI Key Players Head office and Products Offered
Table 17. Coagulation Factor XI Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Coagulation Factor XI Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Coagulation Factor XI Market Size Market Share by Regions (2017-2022)
Table 22. Americas Coagulation Factor XI Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Coagulation Factor XI Market Size Market Share by Country (2017-2022)
Table 24. Americas Coagulation Factor XI Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Coagulation Factor XI Market Size Market Share by Type (2017-2022)
Table 26. Americas Coagulation Factor XI Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Coagulation Factor XI Market Size Market Share by Application (2017-2022)
Table 28. APAC Coagulation Factor XI Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Coagulation Factor XI Market Size Market Share by Region (2017-2022)
Table 30. APAC Coagulation Factor XI Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Coagulation Factor XI Market Size Market Share by Type (2017-2022)
Table 32. APAC Coagulation Factor XI Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Coagulation Factor XI Market Size Market Share by Application (2017-2022)
Table 34. Europe Coagulation Factor XI Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Coagulation Factor XI Market Size Market Share by Country (2017-2022)
Table 36. Europe Coagulation Factor XI Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Coagulation Factor XI Market Size Market Share by Type (2017-2022)
Table 38. Europe Coagulation Factor XI Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Coagulation Factor XI Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Coagulation Factor XI Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Coagulation Factor XI Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Coagulation Factor XI Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Coagulation Factor XI Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Coagulation Factor XI Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Coagulation Factor XI Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Coagulation Factor XI
Table 47. Key Market Challenges & Risks of Coagulation Factor XI
Table 48. Key Industry Trends of Coagulation Factor XI
Table 49. Global Coagulation Factor XI Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Coagulation Factor XI Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Coagulation Factor XI Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Coagulation Factor XI Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Coagulation Factor XI Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Coagulation Factor XI Market Size Market Share Forecast by Application (2023-2028)
Table 55. Bayer AG Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 56. Bayer AG Coagulation Factor XI Product Offered
Table 57. Bayer AG Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Bayer AG Main Business
Table 59. Bayer AG Latest Developments
Table 60. Bristol-Myers Squibb Company Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Company Coagulation Factor XI Product Offered
Table 62. Bristol-Myers Squibb Company Main Business
Table 63. Bristol-Myers Squibb Company Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Bristol-Myers Squibb Company Latest Developments
Table 65. Cambryn Biologics LLC Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 66. Cambryn Biologics LLC Coagulation Factor XI Product Offered
Table 67. Cambryn Biologics LLC Main Business
Table 68. Cambryn Biologics LLC Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Cambryn Biologics LLC Latest Developments
Table 70. eXithera Pharmaceuticals, Inc Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 71. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Offered
Table 72. eXithera Pharmaceuticals, Inc Main Business
Table 73. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. eXithera Pharmaceuticals, Inc Latest Developments
Table 75. Ionis Pharmaceuticals, Inc. Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 76. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Offered
Table 77. Ionis Pharmaceuticals, Inc. Main Business
Table 78. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Ionis Pharmaceuticals, Inc. Latest Developments
Table 80. LegoChem Biosciences, Inc Details, Company Type, Coagulation Factor XI Area Served and Its Competitors
Table 81. LegoChem Biosciences, Inc Coagulation Factor XI Product Offered
Table 82. LegoChem Biosciences, Inc Main Business
Table 83. LegoChem Biosciences, Inc Coagulation Factor XI Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. LegoChem Biosciences, Inc Latest Developments
List of Figures
Figure 1. Coagulation Factor XI Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Coagulation Factor XI Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Coagulation Factor XI Market Size Market Share by Type in 2021
Figure 7. Coagulation Factor XI in Thrombosis
Figure 8. Global Coagulation Factor XI Market: Thrombosis (2017-2022) & ($ Millions)
Figure 9. Coagulation Factor XI in Bleeding and Clotting Disorders
Figure 10. Global Coagulation Factor XI Market: Bleeding and Clotting Disorders (2017-2022) & ($ Millions)
Figure 11. Coagulation Factor XI in Acute Ischemic Stroke
Figure 12. Global Coagulation Factor XI Market: Acute Ischemic Stroke (2017-2022) & ($ Millions)
Figure 13. Coagulation Factor XI in Others
Figure 14. Global Coagulation Factor XI Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Coagulation Factor XI Market Size Market Share by Application in 2021
Figure 16. Global Coagulation Factor XI Revenue Market Share by Player in 2021
Figure 17. Global Coagulation Factor XI Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Coagulation Factor XI Market Size 2017-2022 ($ Millions)
Figure 19. APAC Coagulation Factor XI Market Size 2017-2022 ($ Millions)
Figure 20. Europe Coagulation Factor XI Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Coagulation Factor XI Market Size 2017-2022 ($ Millions)
Figure 22. Americas Coagulation Factor XI Value Market Share by Country in 2021
Figure 23. Americas Coagulation Factor XI Consumption Market Share by Type in 2021
Figure 24. Americas Coagulation Factor XI Market Size Market Share by Application in 2021
Figure 25. United States Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Coagulation Factor XI Market Size Market Share by Region in 2021
Figure 30. APAC Coagulation Factor XI Market Size Market Share by Application in 2021
Figure 31. China Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Coagulation Factor XI Market Size Market Share by Country in 2021
Figure 38. Europe Coagulation Factor XI Market Size Market Share by Type in 2021
Figure 39. Europe Coagulation Factor XI Market Size Market Share by Application in 2021
Figure 40. Germany Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Coagulation Factor XI Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Coagulation Factor XI Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Coagulation Factor XI Market Size Market Share by Application in 2021
Figure 48. Egypt Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Coagulation Factor XI Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 54. APAC Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 55. Europe Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 57. United States Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 58. Canada Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 61. China Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 62. Japan Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 63. Korea Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 65. India Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 66. Australia Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 67. Germany Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 68. France Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 69. UK Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 70. Italy Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 71. Russia Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 72. Spain Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 75. Israel Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Coagulation Factor XI Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Coagulation Factor XI Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...